Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Rite Aid

DB:RTA1
Snowflake Description

Fair value with imperfect balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
RTA1
DB
$646M
Market Cap
  1. Home
  2. DE
  3. Consumer Retailing
Company description

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The last earnings update was 93 days ago. More info.


Add to Portfolio Compare Print
  • Rite Aid has significant price volatility in the past 3 months.
RTA1 Share Price and Events
7 Day Returns
-36%
DB:RTA1
1.9%
Europe Consumer Retailing
4.3%
DE Market
1 Year Returns
11.7%
DB:RTA1
-5.5%
Europe Consumer Retailing
-14.2%
DE Market
RTA1 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Rite Aid (RTA1) -36% -17.8% - 11.7% -87.4% -92.9%
Europe Consumer Retailing 1.9% 0.6% -6.2% -5.5% -9% -18.9%
DE Market 4.3% -9% -21.6% -14.2% -19.6% -25.6%
1 Year Return vs Industry and Market
  • RTA1 outperformed the Consumer Retailing industry which returned -5.5% over the past year.
  • RTA1 outperformed the Market in Germany which returned -14.2% over the past year.
Price Volatility
RTA1
Industry
5yr Volatility vs Market
Related Companies

RTA1 Value

 Is Rite Aid undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Rite Aid to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Rite Aid.

DB:RTA1 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 4 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 10.5%
Perpetual Growth Rate 10-Year DE Government Bond Rate -0.4%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:RTA1
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate -0.4%
Equity Risk Premium S&P Global 5.4%
Consumer Retailing Unlevered Beta Simply Wall St/ S&P Global 0.39
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.391 (1 + (1- 21%) (1056.3%))
2.781
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
2
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= -0.39% + (2 * 5.44%)
10.49%

Discounted Cash Flow Calculation for DB:RTA1 using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Rite Aid is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

DB:RTA1 DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 10.49%)
2020 410.00 Analyst x1 371.07
2021 366.00 Analyst x1 299.80
2022 596.33 Est @ 62.93% 442.10
2023 858.33 Est @ 43.94% 575.92
2024 1,121.30 Est @ 30.64% 680.94
2025 1,360.46 Est @ 21.33% 747.74
2026 1,561.99 Est @ 14.81% 777.00
2027 1,722.14 Est @ 10.25% 775.33
2028 1,843.72 Est @ 7.06% 751.25
2029 1,932.67 Est @ 4.82% 712.74
Present value of next 10 years cash flows $6,133.00
DB:RTA1 DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $1,932.67 × (1 + -0.39%) ÷ (10.49% – -0.39%)
$17,694.24
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $17,694.24 ÷ (1 + 10.49%)10
$6,525.33
DB:RTA1 Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $6,133.00 + $6,525.33
$12,658.33
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $12,658.33 / 53.78
$235.38
DB:RTA1 Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:RTA1 represents 0.9169x of NYSE:RAD
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.9169x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (USD) x Listing Adjustment Factor
= $ 235.38 x 0.9169
€215.82
Value per share (EUR) From above. €215.82
Current discount Discount to share price of €11.01
= -1 x (€11.01 - €215.82) / €215.82
94.9%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Rite Aid is available for.
Intrinsic value
>50%
Share price is €11.01 vs Future cash flow value of €215.82
Current Discount Checks
For Rite Aid to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Rite Aid's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Rite Aid's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Rite Aid's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Rite Aid's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:RTA1 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-11-30) in USD $-7.18
NYSE:RAD Share Price ** NYSE (2020-04-08) in USD $12.01
Europe Consumer Retailing Industry PE Ratio Median Figure of 39 Publicly-Listed Consumer Retailing Companies 18.53x
Germany Market PE Ratio Median Figure of 402 Publicly-Listed Companies 17.07x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Rite Aid.

DB:RTA1 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:RAD Share Price ÷ EPS (both in USD)

= 12.01 ÷ -7.18

-1.67x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Rite Aid is loss making, we can't compare its value to the Europe Consumer Retailing industry average.
  • Rite Aid is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does Rite Aid's expected growth come at a high price?
Raw Data
DB:RTA1 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -1.67x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 4 Analysts
47%per year
Europe Consumer Retailing Industry PEG Ratio Median Figure of 25 Publicly-Listed Consumer Retailing Companies 1.1x
Germany Market PEG Ratio Median Figure of 256 Publicly-Listed Companies 1.24x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Rite Aid, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Rite Aid's assets?
Raw Data
DB:RTA1 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-11-30) in USD $19.06
NYSE:RAD Share Price * NYSE (2020-04-08) in USD $12.01
Europe Consumer Retailing Industry PB Ratio Median Figure of 50 Publicly-Listed Consumer Retailing Companies 1.33x
Germany Market PB Ratio Median Figure of 573 Publicly-Listed Companies 1.47x
DB:RTA1 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:RAD Share Price ÷ Book Value per Share (both in USD)

= 12.01 ÷ 19.06

0.63x

* Primary Listing of Rite Aid.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Rite Aid is good value based on assets compared to the Europe Consumer Retailing industry average.
X
Value checks
We assess Rite Aid's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Consumer Retailing industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Consumer Retailing industry average (and greater than 0)? (1 check)
  5. Rite Aid has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

RTA1 Future Performance

 How is Rite Aid expected to perform in the next 1 to 3 years based on estimates from 4 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
47%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Rite Aid expected to grow at an attractive rate?
  • Unable to compare Rite Aid's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.
Growth vs Market Checks
  • Unable to compare Rite Aid's earnings growth to the Germany market average as it is expected to be loss making during the next 1-3 years.
  • Rite Aid's revenue growth is positive but not above the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:RTA1 Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:RTA1 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 4 Analysts 47%
DB:RTA1 Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 4 Analysts 1.9%
Europe Consumer Retailing Industry Earnings Growth Rate Market Cap Weighted Average 17.9%
Europe Consumer Retailing Industry Revenue Growth Rate Market Cap Weighted Average 3.4%
Germany Market Earnings Growth Rate Market Cap Weighted Average 14.1%
Germany Market Revenue Growth Rate Market Cap Weighted Average 3.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:RTA1 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:RTA1 Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-02-28 22,977 -62 1
2022-02-28 22,715 -61 4
2021-02-28 22,527 433 -81 4
2020-04-08
2020-02-29 21,837 351 -179 4
DB:RTA1 Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-11-30 21,581 -145 -381
2019-08-31 21,569 -198 -451
2019-06-01 21,624 -203 -725
2019-03-02 21,640 -229 -667
2018-12-01 21,654 -93 -895
2018-09-01 21,557 -394 -896
2018-06-02 21,481 83 -355
2018-03-03 21,529 266 -350
2017-12-02 22,038 423 109
2017-09-02 22,354 511 151
2017-06-03 20,180 165 -27
2017-03-04 22,928 232 4

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Rite Aid is not considered high growth as it is expected to be loss making for the next 1-3 years.
  • Rite Aid's revenue is expected to grow by 1.9% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:RTA1 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below

All data from Rite Aid Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:RTA1 Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-02-28 -1.13 -1.13 -1.13 1.00
2022-02-28 -1.12 -1.12 -1.12 1.00
2021-02-28 -1.50 -1.07 -1.93 2.00
2020-04-08
2020-02-29 -3.35 -3.25 -3.45 2.00
DB:RTA1 Past Financials Data
Date (Data in USD Millions) EPS *
2019-11-30 -7.18
2019-08-31 -8.51
2019-06-01 -13.69
2019-03-02 -12.62
2018-12-01 -16.96
2018-09-01 -17.01
2018-06-02 -6.76
2018-03-03 -6.66
2017-12-02 2.08
2017-09-02 2.88
2017-06-03 -0.52
2017-03-04 0.08

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Rite Aid will efficiently use shareholders’ funds in the future (Return on Equity greater than 20%) as it is not expected to be profitable.
X
Future performance checks
We assess Rite Aid's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Rite Aid has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

RTA1 Past Performance

  How has Rite Aid performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Rite Aid's growth in the last year to its industry (Consumer Retailing).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Rite Aid does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Rite Aid's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Rite Aid's 1-year growth to the Europe Consumer Retailing industry average as it is not currently profitable.
Earnings and Revenue History
Rite Aid's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Rite Aid Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:RTA1 Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-11-30 21,580.80 -381.39 4,444.65
2019-08-31 21,568.56 -450.92 4,477.62
2019-06-01 21,623.66 -724.57 4,503.23
2019-03-02 21,639.56 -666.95 4,536.55
2018-12-01 21,654.18 -895.00 4,606.13
2018-09-01 21,557.29 -895.93 4,612.81
2018-06-02 21,480.94 -355.22 4,618.67
2018-03-03 21,528.97 -349.53 4,626.98
2017-12-02 22,038.09 109.09 4,705.17
2017-09-02 22,354.03 150.88 4,730.58
2017-06-03 20,179.88 -27.37 4,144.69
2017-03-04 22,927.54 4.08 4,777.00
2016-11-26 25,294.29 94.75 5,306.66
2016-08-27 27,779.36 130.68 5,909.66
2016-05-28 32,273.28 142.04 7,079.53
2016-02-27 20,770.24 102.09 4,581.17
2015-11-28 29,314.45 1,934.88 6,905.94
2015-08-29 27,852.60 1,980.18 6,820.73
2015-05-30 26,710.41 2,086.56 6,735.43
2015-02-28 26,528.38 2,109.17 6,680.20
2014-11-29 26,277.91 329.52 6,693.99
2014-08-30 25,943.31 267.78 6,633.85
2014-05-31 25,698.89 169.96 6,596.26
2014-03-01 25,526.41 215.42 6,561.16
2013-11-30 25,384.20 280.41 6,526.82
2013-08-31 25,264.31 296.50 6,545.72
2013-06-01 25,217.03 225.07 6,560.96

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Rite Aid has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Rite Aid has efficiently used its assets last year compared to the Europe Consumer Retailing industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Rite Aid improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Rite Aid's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Consumer Retailing industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Rite Aid has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

RTA1 Health

 How is Rite Aid's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Rite Aid's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Rite Aid is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Rite Aid's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Rite Aid's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Rite Aid Company Filings, last reported 4 months ago.

DB:RTA1 Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-11-30 1,015.86 3,566.26 289.50
2019-08-31 960.59 3,834.61 149.13
2019-06-01 1,035.22 3,582.04 190.45
2019-03-02 1,186.69 3,454.59 151.54
2018-12-01 1,453.41 3,394.56 417.25
2018-09-01 1,455.95 3,481.83 132.47
2018-06-02 1,812.31 3,134.79 147.09
2018-03-03 1,601.01 3,340.19 447.33
2017-12-02 825.14 2,985.79 169.80
2017-09-02 733.61 7,082.64 238.98
2017-06-03 560.63 7,178.01 221.47
2017-03-04 614.07 3,235.98 252.28
2016-11-26 646.13 7,208.38 226.92
2016-08-27 616.67 7,173.75 142.29
2016-05-28 591.50 6,899.12 144.84
2016-02-27 581.43 6,914.48 124.47
2015-11-28 500.83 7,288.00 226.25
2015-08-29 429.70 7,361.17 152.65
2015-05-30 152.73 7,147.62 1,922.13
2015-02-28 57.06 5,467.12 115.90
2014-11-29 -1,792.66 5,754.62 232.95
2014-08-30 -1,906.53 5,651.61 185.76
2014-05-31 -2,046.35 5,600.62 166.00
2014-03-01 -2,113.70 5,649.73 146.41
2013-11-30 -2,228.83 5,842.69 183.21
2013-08-31 -2,317.87 5,932.72 144.17
2013-06-01 -2,357.52 5,795.53 108.90
  • Rite Aid's level of debt (351.1%) compared to net worth is high (greater than 40%).
  • Rite Aid had negative shareholder equity 5 years ago, it is now positive therefore their debt level has improved.
  • Operating cash flow is negative therefore debt is not well covered.
  • Rite Aid is making a loss, therefore interest payments are not well covered by earnings.
X
Financial health checks
We assess Rite Aid's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Rite Aid has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

RTA1 Dividends

 What is Rite Aid's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Rite Aid dividends. Estimated to be 0% next year.
If you bought €2,000 of Rite Aid shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Rite Aid's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Rite Aid's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:RTA1 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below
Europe Consumer Retailing Industry Average Dividend Yield Market Cap Weighted Average of 35 Stocks 3.9%
Germany Market Average Dividend Yield Market Cap Weighted Average of 314 Stocks 3.6%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.6%
Germany Top 25% Dividend Yield 75th Percentile 4.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:RTA1 Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2023-02-28
2022-02-28 0.00 1.00
2021-02-28 0.00 1.00
2020-04-08
2020-02-29 0.00 1.00

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Rite Aid has not reported any payouts.
  • Unable to verify if Rite Aid's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Rite Aid's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Rite Aid has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Rite Aid's dividends in 3 years as they are not expected to pay a notable one for Germany.
X
Income/ dividend checks
We assess Rite Aid's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Rite Aid afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Rite Aid has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

RTA1 Management

 What is the CEO of Rite Aid's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Heyward Donigan
AGE 58
TENURE AS CEO 0.7 years
CEO Bio

Ms. Heyward Rutledge Donigan, B. A. has been Chief Executive Officer and a Member of The Board of Rite Aid Corporation since August 23, 2019 and serves as its President at Rite Aid Corporation since February 05, 2020. Ms. Donigan served as President, Chief Executive Officer and Director of Vitals Consumer Services, LLC. She served as President, Chief Executive Officer and Director of Sapphire Digital, formerly, Vitals, a leading consumer transparency company, since March 2015. She has been the Chief Executive Officer of MDX Medical, Inc. since March 10, 2015 and serves as its President. Ms. Donigan served as Director at SI-BONE, Inc. since June 17, 2019 until August 13, 2019. Ms. Donigan has served as President, Chief Executive Officer and director of Vitals since March 2015. From 2010 to 2014, Ms. Donigan served as President, Chief Executive Officer and a director of ValueOptions, Inc. She is a recognized leader and has experience in all aspects of the healthcare industry. She has a passion for building and developing strong teams to deliver innovative offerings in the market. She served as the Chief Marketing Executive and Executive Vice President of Premera Blue Cross since 2003 until September 2010. She has all facets of the health plan business, including network management, contracting, sales and marketing, product development and operations. Prior to Premera, she was at CIGNA Healthcare, where she served as Senior Vice President of service operations, President of the Southeast region and General Manager of the Georgia/Alabama markets. She also directed transformation project to develop new products, reengineer business processes and develop and enhance systems. She worked for Empire Blue Cross and Blue Shield and US Healthcare. She also held executive roles at General Electric. She has held a number of leadership positions across many disciplines, including Operations, sales, marketing, network management and contracting and product development. She had served as a Director of Nxstage Medical, Inc. since July 2016 until February 21, 2019. She served as an Independent Director of Kindred Healthcare Inc. since March 27, 2014 until July 2, 2018. Ms. Donigan holds a Bachelor of Arts in English from the University of Virginia and a Master’s of Public Administration Degree in Health Care Finance from New York University.

CEO Compensation
  • Insufficient data for Heyward to compare compensation growth.
  • Insufficient data for Heyward to establish whether their remuneration is reasonable compared to companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the Rite Aid management team in years:

1.3
Average Tenure
54
Average Age
  • The average tenure for the Rite Aid management team is less than 2 years, this suggests a new team.
Management Team

Jocelyn Konrad

TITLE
Executive VP & Chief Pharmacy Officer
COMPENSATION
$1M
AGE
49
TENURE
4.7 yrs

Heyward Donigan

TITLE
President CEO & Director
AGE
58
TENURE
0.7 yrs

Matt Schroeder

TITLE
CFO & Executive VP
AGE
49
TENURE
1.1 yrs

Jim Peters

TITLE
Chief Operating Officer
AGE
47
TENURE
0.5 yrs

Brian Hoover

TITLE
Chief Accounting Officer
AGE
54
TENURE
1.1 yrs

Justin Mennen

TITLE
Executive VP & Chief Information Officer
TENURE
1.3 yrs

Byron Purcell

TITLE
Senior Director of Treasury Services & Investor Relations

Jim Comitale

TITLE
Executive VP
TENURE
4.4 yrs

Susan Henderson

TITLE
Chief Communications Officer & Senior VP
AGE
66
TENURE
8.7 yrs

Frank Vitrano

TITLE
Chief Strategic Business Development Officer
COMPENSATION
$1M
AGE
64
TENURE
4.5 yrs
Board of Directors Tenure

Average tenure and age of the Rite Aid board of directors in years:

1.5
Average Tenure
64
Average Age
  • The average tenure for the Rite Aid board of directors is less than 3 years, this suggests a new board.
Board of Directors

Bruce Bodaken

TITLE
Independent Chairman of the Board
COMPENSATION
$237K
AGE
67
TENURE
1.5 yrs

Heyward Donigan

TITLE
President CEO & Director
AGE
58
TENURE
0.7 yrs

Kevin Lofton

TITLE
Independent Director
COMPENSATION
$230K
AGE
64
TENURE
6.4 yrs

Bob Knowling

TITLE
Independent Director
COMPENSATION
$139K
AGE
64
TENURE
1.5 yrs

Lou Miramontes

TITLE
Independent Director
COMPENSATION
$146K
AGE
64
TENURE
1.5 yrs

Marcy Syms

TITLE
Independent Director
COMPENSATION
$232K
AGE
68
TENURE
14.6 yrs

Arun Nayar

TITLE
Independent Director
COMPENSATION
$139K
AGE
68
TENURE
1.5 yrs

Busy Burr

TITLE
Independent Director
AGE
57
TENURE
1 yrs

Kate Quinn

TITLE
Independent Director
AGE
54
TENURE
1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Rite Aid's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Rite Aid has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

RTA1 News

Simply Wall St News

RTA1 Company Info

Description

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and an assortment of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. It also operates retail clinics that provide treatment for common conditions; and provides preventative services, such as screenings, medical tests, immunizations, and basic physical exams. In addition, this segment offers healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; and offers integrated mail-order and specialty pharmacy services, as well as drug benefits under the federal government's Medicare Part D program. As of April 11, 2019, the company operated 2,469 stores in 18 states. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.

Details
Name: Rite Aid Corporation
RTA1
Exchange: DB
Founded: 1927
$593,947,074
53,778,140
Website: http://www.riteaid.com
Address: Rite Aid Corporation
30 Hunter Lane,
Camp Hill,
Pennsylvania, 17011,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE RAD Common Stock New York Stock Exchange US USD 07. Oct 1968
DB RTA1 Common Stock Deutsche Boerse AG DE EUR 07. Oct 1968
Number of employees
Current staff
Staff numbers
42,645
Rite Aid employees.
Industry
Drug Retail
Consumer Retailing
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/08 22:55
End of day share price update: 2020/04/08 00:00
Last estimates confirmation: 2020/03/30
Last earnings filing: 2020/01/06
Last earnings reported: 2019/11/30
Last annual earnings reported: 2019/03/02


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.